Medicare Enrolled
Dr. Aliakbar Dadla, M.D.
Student in an Organized Health Care Education/Training Program · Vancouver, WA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dadla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dadla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dadla
Dr. Aliakbar Dadla is a student in an organized health care education/training program specialist in Vancouver, WA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Dadla performed 50,042 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dadla received a total of $4,424 from 53 pharmaceutical and/or device companies across 252 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dadla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ Top 0% volume in WA
$4,424 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗50,042
Medicare services
Top 0% in WA for student in an organized health care education/training program
Not available
Unique patients (not deduplicated)
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
20,400 | $0 | $2 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
13,350 | $0 | $0 |
| Pembrolizumab injection (Keytruda) | 9,600 | $44 | $92 |
| Denosumab injection (Prolia/Xgeva) | 1,380 | $18 | $36 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
996 | $0 | $2 |
| Anti-nausea injection (Aloxi/palonosetron) | 890 | $1 | $2 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
392 | $2 | $5 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
328 | $86 | $220 |
| Anti-nausea injection (ondansetron/Zofran) | 272 | $0 | $1 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
260 | $134 | $297 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
212 | $12 | $52 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
212 | $106 | $322 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
151 | $6 | $21 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
123 | $10 | $36 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
123 | $11 | $52 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
110 | $70 | $70 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
106 | $23 | $75 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 103 | $126 | $367 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
97 | $1 | $2 |
| New patient office visit, complex (60-74 min) | 96 | $154 | $403 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
88 | $23 | $75 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
76 | $51 | $150 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
74 | $26 | $100 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
71 | $8 | $13 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
69 | $8 | $16 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
58 | $1 | $1 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
56 | $52 | $160 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
50 | $10 | $22 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
45 | $62 | $151 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
41 | $30 | $119 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
39 | $137 | $250 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
35 | $59 | $148 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
32 | $1 | $2 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
27 | $2 | $4 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
26 | $26 | $123 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
21 | $13 | $28 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $133 | $432 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
13 | $21 | $55 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
42.0% high complexity
55.4% medium
2.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,424
Total received (2018-2024)
Avg $632/year across 7 years
Top 6% in WA for student in an organized health care education/training program
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
252
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,112
2023
$424
2022
$24
2021
$111
2020
$381
2019
$1,521
2018
$850
Payments by company (2024)
PFIZER INC.
$214
Merck Sharp & Dohme LLC
$188
AstraZeneca Pharmaceuticals LP
$139
Daiichi Sankyo Inc.
$90
ABBVIE INC.
$57
E.R. Squibb & Sons, L.L.C.
$43
Janssen Biotech, Inc.
$42
Stemline Therapeutics Inc.
$34
Coherus Biosciences Inc.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
BeiGene USA, Inc.
$31
Takeda Pharmaceuticals U.S.A., Inc.
$28
Regeneron Healthcare Solutions, Inc.
$26
GENZYME CORPORATION
$25
Mirati Therapeutics, Inc.
$22
Genmab U.S., Inc.
$22
Deciphera Pharmaceuticals Inc.
$21
Celgene Corporation
$20
GlaxoSmithKline, LLC.
$16
Incyte Corporation
$16
Eisai Inc.
$13
Top 3 companies account for 48.7% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$434
E.R. Squibb & Sons, L.L.C.
$388
Merck Sharp & Dohme Corporation
$334
Merck Sharp & Dohme LLC
$210
AstraZeneca Pharmaceuticals LP
$207
Novartis Pharmaceuticals Corporation
$206
Amgen Inc.
$179
Janssen Biotech, Inc.
$175
Daiichi Sankyo Inc.
$160
Genentech USA, Inc.
$154
Alexion Pharmaceuticals, Inc.
$150
Astellas Pharma US Inc
$126
Lilly USA, LLC
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$105
EISAI INC.
$96
Celgene Corporation
$91
Pharmacyclics LLC, An AbbVie Company
$75
Eisai Inc.
$73
Takeda Pharmaceuticals U.S.A., Inc.
$71
Incyte Corporation
$62
GENZYME CORPORATION
$61
Exelixis Inc.
$57
ABBVIE INC.
$57
Regeneron Healthcare Solutions, Inc.
$56
SANOFI-AVENTIS U.S. LLC
$50
Mirati Therapeutics, Inc.
$47
JAZZ PHARMACEUTICALS INC.
$43
Seagen Inc.
$42
Puma Biotechnology, Inc.
$36
Foundation Medicine, Inc.
$36
Janssen Pharmaceuticals, Inc
$35
Stemline Therapeutics Inc.
$34
Coherus Biosciences Inc.
$33
Blueprint Medicines Corporation
$32
BeiGene USA, Inc.
$31
Bayer HealthCare Pharmaceuticals Inc.
$30
Seattle Genetics, Inc.
$29
Dendreon Pharmaceuticals LLC
$28
Gilead Sciences, Inc.
$25
Clovis Oncology, Inc.
$23
Rigel Pharmaceuticals, Inc.
$23
CTI BioPharma Corp.
$22
Genmab U.S., Inc.
$22
Deciphera Pharmaceuticals Inc.
$21
Blue Earth Diagnostics Limited
$18
AbbVie, Inc.
$18
GlaxoSmithKline, LLC.
$16
Grifols USA, LLC
$15
AbbVie Inc.
$14
Kite Pharma, Inc.
$14
Helsinn Therapeutics (U.S.), Inc.
$12
Dova Pharmaceuticals
$12
Kyowa Kirin, Inc.
$12
Top 3 companies account for 26.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AYVAKIT · Alphanate · Aranesp · Avastin · Axumin · BRUKINSA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELITEK · EMPLICITI · ENHERTU · ERBITUX · ERLEADA · Enhertu · Epkinly · FOUNDATIONONE · FRUZAQLA · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEMPERLI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LYNPARZA · Lenvima · MEKINIST · MVASI · NINLARO · Nerlynx · Neulasta · Nplate · OFEV · OPDIVO · OPDUALAG · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Perjeta · Pomalyst · QINLOCK · REBLOZYL · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SUTENT · Stivarga · TAGRISSO · TECVAYLI · TUKYSA · Tavalisse · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Vanflyta · Venclexta · Vonjo · XALKORI · XARELTO · XTANDI · Yescarta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Student in an organized health care education/training programs in nearby ZIP areas
3,222
County median income
$94,948
Nearest hospital to ZIP centroid (approximate)
PEACEHEALTH SOUTHWEST MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dadla is a mixed practice specialist, with above-average Medicare volume (top 0% in WA).
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dadla experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Dadla performed 20,400 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dadla receive payments from pharmaceutical companies?
Yes. Dr. Dadla received a total of $4,424 from 53 companies across 252 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dadla's costs compare to other student in an organized health care education/training programs in Vancouver?
Dr. Dadla's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dadla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Student In An Organized Health Care Education/training Programs in Vancouver
Browse student in an organized health care education/training programs in Vancouver ranked by procedure volume and transparency data.
Highest volume
Top Student In An Organized Health Care Education/training Programs in WA
Student in an organized health care education/training programs ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Student In An Organized Health Care Education/training Programs in WA
Which WA student in an organized health care education/training programs receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology